Global News

RPS appoints Stephen Kasay as CIO

Thursday, August 30, 2012 03:02 PM

ReSearch Pharmaceutical Services (RPS), a Fort Washington, Penn.-based next generation global CRO that provides comprehensive phase I-IV clinical development solutions, has appointed Stephen Kasay as chief information officer.

More... »

Y-Prime names Greef as senior business analyst

Thursday, August 30, 2012 02:53 PM

Y-Prime Technologies, an Malvern, Penn.-based eClinical products and life sciences consulting services company, has expanded its international operations in Europe and has named Jeanette Anne Greef as senior business analyst in the U.K. office.

More... »

QED Clinical Services to launch OrphanReach drug development division

Thursday, August 30, 2012 11:13 AM

QED Clinical Services, a global niche CRO operating, is launching OrphanReach, a division to develop drugs in rare disease areas.

More... »

Charles River acquires Accugenix

Thursday, August 30, 2012 10:35 AM

Charles River Laboratories International, a global provider of research products and services, has acquired Accugenix, a global provider of cGMP-compliant contract microbial identification testing, for approximately $17 million in cash.

More... »

Oncologists restrict pharmaceutical sales rep access at accelerating rates

Wednesday, August 29, 2012 01:37 PM

As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives face a rising hurdle—oncologists are reducing the number of times they will see them.

More... »

QPS acquires JSW Life Sciences

Wednesday, August 29, 2012 09:47 AM

QPS, a global full-service GLP/GCP-compliant CRO based in Newark, Del., has acquired a majority interest in JSW Life Sciences, a provider of preclinical and clinical phase II-IV drug development services. The company will be known as QPS JSW.

More... »

Pascal Soriot named AstraZeneca CEO

Tuesday, August 28, 2012 03:06 PM

AstraZeneca has announced Pascal Soriot’s appointment as the company’s chief executive officer. He will assume the new role and join the AstraZeneca board as an executive director as of Oct. 1.

More... »

Marken expands four facilities

Tuesday, August 28, 2012 12:30 PM

Marken, based in Research Triangle Park, N.C., has opened four expanded branch facilities to meet continued growth.

More... »

INC Research wins IACET accreditation for corporate training

Tuesday, August 28, 2012 12:26 PM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO, has been accredited as an authorized provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs. INC says it is the only global CRO authorized provider offering Continuing Education Units (CEUs) that qualify under the ANSI/IACET standard.

More... »

United Drug to acquire pharmacovigilance, market access companies

Tuesday, August 28, 2012 12:21 PM

United Drug, an international provider of healthcare services, will acquire North Carolina-based Drug Safety Alliance for a total of up to $28 million, and North Carolina-based Synopia RX for up to $12 million.

More... »